Q. Dwight Lewis has been appointed vice president of quality for Mayne Pharma’s operations in the U.S. Mr. Lewis is responsible for managing all quality-related functions to ensure U.S. pharmaceutical operations, from labs to manufacturing lines, continue to comply with global regulatory and industry standards.
 
Prior to joining the company, Mr. Lewis was senior director of quality for Teva Pharmaceuticals, where he managed quality assurance and control functions for solid dose manufacturing. He also served as vice president of quality for Irix Pharmaceuticals, and director of quality operations for DSM Pharmaceuticals.
 
“Drug product integrity doesn’t occur spontaneously; it is the result of thoughtfully considered and deliberately executed quality standards and operations,” said Stefan Cross, president of Mayne Pharma’s U.S. operations. “Dwight’s knowledge and expertise in quality compliance and assurance will support Mayne Pharma’s ability to deliver superior pharmaceutical services and products to our clients and the patients we collectively serve.”